Apolipoprotein E polymorphism and carotid artery intima-media thickness in a random sample of middle-aged men

被引:50
作者
Ilveskoski, E
Loimaala, A
Mercuri, MF
Lehtimäki, T
Pasanen, M
Nenonen, A
Oja, P
Bond, MG
Koivula, T
Karhunen, PJ
Vuori, I
机构
[1] Tampere Univ Hosp, Dept Clin Chem, Lab Atherosclerosis Genet, FIN-33521 Tampere, Finland
[2] UKK Inst Hlth Promot Res, Tampere, Finland
[3] Tampere Univ, Sch Med, FIN-33101 Tampere, Finland
[4] Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC USA
关键词
apolipoprotein E; polymorphism; carotid atherosclerosis; ultrasonics; intima-media thickness;
D O I
10.1016/S0021-9150(00)00383-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Genetic polymorphism of apolipoprotein E (apoE) is an important factor in the development of coronary artery disease but the results concerning apoE genotype and carotid artery atherosclerosis remain controversial. We investigated a random sample of 189 Finnish middle aged men (mean age 54 years, range 50-59) to assess the role of apoE in the process of carotid atherosclerosis. Intima-media thickness (IMT) of the carotid artery wall was measured at three standardised segments (common carotid artery, bifurcation and internal carotid artery) by B-mode ultrasonography. Overall mean IMT value was also calculated. The carriers of E3/2 (n = 20) genotype had significantly lower (P < 0.01) total cholesterol and LDL cholesterol concentrations than carriers of E3/3 genotype (rl = 109) or the E4 allele (n = 60). ApoE polymorphism was associated with common carotid artery IMT (P = 0.034) when adjusted for age and body-mass index (model 1). The carriers of E3/2 had on average 9%, (95% CI 0.8-16%, P = 0.028) lower common carotid IMT values than the carriers of E3/3. After further adjustment with LDL and HDL cholesterol, systolic blood pressure, lipoprotein (a), apolipoprotein B and pack-years of smoking (model 2) the association was not statistically significant. The overall mean IMT varied significantly with apoE genotype (P = 0.03 for model 1 and P = 0.07 for model 2), and it was also lowest in the carriers of E3/2 genotype. This suggests that apoE E3/2 genotype is a protective factor in the development of carotid artery atherosclerosis in randomly selected middle-aged men. The favourable effect might be mediated at least partly by the lowering effect of E3/2 genotype on serum cholesterol. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:147 / 153
页数:7
相关论文
共 39 条
[1]  
Carlson K, 1973, J Clin Pathol Suppl (Assoc Clin Pathol), V5, P32
[2]   Polymorphism of the apolipoprotein E gene and early carotid atherosclerosis defined by ultrasonography in asymptomatic adults [J].
Cattin, L ;
Fisicaro, M ;
Tonizzo, M ;
Valenti, M ;
Danek, GM ;
Fonda, M ;
DaCol, PG ;
Casagrande, S ;
Pincetti, E ;
Bovenzi, M ;
Baralle, F .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (01) :91-94
[3]   PREVALENCE OF APOLIPOPROTEIN-E PHENOTYPES IN ISCHEMIC CEREBROVASCULAR-DISEASE - A CASE-CONTROL STUDY [J].
COUDERC, R ;
MAHIEUX, F ;
BAILLEUL, S ;
FENELON, G ;
MARY, R ;
FERMANIAN, J .
STROKE, 1993, 24 (05) :661-664
[4]   EVALUATION OF THE ASSOCIATIONS BETWEEN CAROTID-ARTERY ATHEROSCLEROSIS AND CORONARY-ARTERY STENOSIS - A CASE-CONTROL STUDY [J].
CRAVEN, TE ;
RYU, JE ;
ESPELAND, MA ;
KAHL, FR ;
MCKINNEY, WM ;
TOOLE, JF ;
MCMAHAN, MR ;
THOMPSON, CJ ;
HEISS, G ;
CROUSE, JR .
CIRCULATION, 1990, 82 (04) :1230-1242
[5]  
DALLONGEVILLE J, 1992, J LIPID RES, V33, P447
[6]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[7]  
DEANDRADE M, 1995, AM J HUM GENET, V56, P1379
[8]  
EHNHOLM C, 1986, J LIPID RES, V27, P227
[9]   RELATION OF APOLIPOPROTEIN E PHENOTYPE TO MYOCARDIAL-INFARCTION AND MORTALITY FROM CORONARY-ARTERY DISEASE [J].
EICHNER, JE ;
KULLER, LH ;
ORCHARD, TJ ;
GRANDITS, GA ;
MCCALLUM, LM ;
FERRELL, RE ;
NEATON, JD .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (02) :160-165
[10]   APOLIPOPROTEIN-E POLYMORPHISM AND HYPERLIPEMIA IN TYPE-II DIABETICS [J].
ETO, M ;
WATANABE, K ;
IWASHIMA, Y ;
MORIKAWA, A ;
OSHIMA, E ;
SEKIGUCHI, M ;
ISHII, K .
DIABETES, 1986, 35 (12) :1374-1382